Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.510
-0.780-4.51%
Volume:8.50M
Turnover:140.91M
Market Cap:43.90B
PE:11.13
High:17.200
Open:17.200
Low:16.360
Close:17.290
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.49
T/O Rate:1.57%
Dividend:0.46
Dividend Rate:2.76%
EPS(LYR):1.483
ROE:6.95%
ROA:1.40%
PB:0.77
PE(LYR):11.13
PS:0.88

Loading ...

Subsidiary of FOSUN PHARMA Gains Approval for Pertuzumab Injection

Stock News
·
May 29

FOSUN PHARMA Invests Over 400 Million Yuan in Nucleic Acid Drug Firm

Deep News
·
May 27

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27

Fosun Pharmaceutical to Invest 414 Million Yuan in Xingyao Kunze's Series B Funding Round

MT Newswires Live
·
May 27

Fosun Pharma Gets Registration Nod for Infection Drug in China

MT Newswires Live
·
May 21

Fosun Pharma receives NMPA clearance for Yaopharma-developed Levofloxacin Injection

Bulletin Express
·
May 21

FOSUN PHARMA Subsidiary Gains Approval for Levofloxacin Injection

Stock News
·
May 21

Shanghai Fosun Pharma - Drug Registration Application for Levofloxacin Injection Approved by China's Nmpa

THOMSON REUTERS
·
May 21

FOSUN PHARMA Subsidiary's HLX3902 Injection Approved for Clinical Trials in Australia

Stock News
·
May 21

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FOSUN PHARMA's Strategic Move: $60 Million Secures Potential Over $2.5 Billion for AR1001

Stock News
·
May 14

Fosun Pharma Secures $60 Million Option for Alzheimer's Drug

MT Newswires Live
·
May 14

China's AI Power Consumption Set to Soar, Spotlight on Computing-Power Synergy

Stock News
·
May 14

Fosun Pharma's Unit's Registration Application for Blood Stasis Syndrome Drug Accepted in China

MT Newswires Live
·
May 13

Fosun Pharma Subsidiary’s Tao Hong Si Wu Tang Granules Secures NMPA Filing Acceptance

Bulletin Express
·
May 13

FOSUN PHARMA's Application for Traditional Chinese Medicine New Drug Accepted for Review

Stock News
·
May 13

Shanghai Fosun Pharma - Drug Registration Applications of Tao Hong Si Wu Tang Granules by Unit Accepted by Nmpa China

THOMSON REUTERS
·
May 13

Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June 2026 H Shareholders Meeting to Seek 10% Dual-Class Buyback Mandates

Bulletin Express
·
May 11